Demonstration of the beta 2-adrenoceptor intrinsic efficacy of AY-28,925 using the PGF2 alpha-contracted guinea-pig trachea

European Journal of Pharmacology
R J HeaslipD Grimes


The abilities of AY-28,925, labetalol and medroxalol to relax the PGF2 alpha-contracted isolated guinea-pig trachea have been investigated to compare their activities at beta 2-adrenoceptors. Maximum relaxation induced by AY-28,925 was significantly greater than that induced by either labetalol or medroxalol. This relaxation occurred in a concentration-dependent manner over a range of concentrations consistent with the previously determined affinity of AY-28,925 for beta-adrenoceptors. ICI-118,551 inhibited AY-28,925-induced relaxation in a concentration-dependent manner with a pA2 value similar to that determined for ICI-118,551 inhibition of the selective beta 2-adrenoceptor agonist salbutamol, but not the selective beta 1-adrenoceptor agonist norepinephrine. The Schild plot slope for ICI-118,551 inhibition of AY-28,925 or salbutamol did not differ significantly from unity, while that for inhibition of isoproterenol (a non-selective beta-adrenoceptor agonist) did. It is concluded that AY-28,925 is a more efficacious relaxant of tracheal smooth muscle than either labetalol or medroxalol, and that this relaxant activity is the result of its greater intrinsic efficacy at the beta 2-adrenoceptor.


Nov 1, 1979·The Journal of Pharmacy and Pharmacology·B Carey, E T Whalley
Jan 1, 1986·Journal of Cardiovascular Pharmacology·A S Tadepalli, P J Novak
Mar 1, 1982·The Journal of Pharmacy and Pharmacology·J K Woodward, H C Cheng
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·A A Hancock
Mar 1, 1981·Journal of Cardiovascular Pharmacology·R C DageJ K Woodward
Jan 1, 1983·Journal of Cardiovascular Pharmacology·R C DageM Spedding
May 1, 1983·Journal of Cardiovascular Pharmacology·A J BilskiJ L Wale
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD


Apr 3, 2001·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Stephanie J Brown, Judith Lumley

Related Concepts

ICI 118551, hydrochloride
Adrenergic beta-Agonists
Adrenergic beta-Antagonists
Cavia porcellus
Smooth Muscle

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.